Tramadol induces conditioned place preference in rats: Interactions with morphine and buprenorphine

Neuroscience Letters

Volumn 520, Issue 1, 2012, Pages 87-91

  Zhang, Min ^a   Jing, Li ^b   Liu, Qing ^a   Wen, Rui Ting ^a   Li, Jun Xu ^c   Li, Yu Ling ^a   Gong, Qi ^a   Liang, Jian Hui ^a  

^a PEKING UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

Buprenorphine; Conditioned place preference; Drug interaction; Morphine; Tramadol

Indexed keywords

BUPRENORPHINE; MORPHINE; TRAMADOL;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; DOSE RESPONSE; DRUG POTENTIATION; MALE; NONHUMAN; OPIATE ADDICTION; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD;

ANALGESICS, OPIOID; ANIMALS; BUPRENORPHINE; CONDITIONING, CLASSICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; MALE; MORPHINE; RATS; RATS, SPRAGUE-DAWLEY; TRAMADOL;

EID: 84862154106     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.05.037     Document Type: Article

References (27)

1. Bardo M.T., Bevins R.A. Conditioned place preference: what does it add to our preclinical understanding of drug reward?. Psychopharmacology 2000, 153:31-43.
2. Cicero T.J., Adams E.H., Geller A., Inciardi J.A., Munoz A., Schnoll S.H., Senay E.C., Woody G.E. A postmarketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States. Drug and Alcohol Dependence 1999, 57:7-22.
3. Degenhardt L., Black E., Breen C., Bruno R., Kinner S., Roxburgh A., Fry C., Jenkinson R., Ward J., Fetherston J., Weekley J., Fischer J. Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia. Drug and Alcohol Review 2006, 25:403-412.
4. Duke A.N., Bigelow G.E., Lanier R.K., Strain E.C. Discriminative stimulus effects of tramadol in humans. Journal of Pharmacology and Experimental Therapeutics 2011, 338:255-262.
5. Epstein D.H., Preston K.L., Jasinski D.R. Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol. Biological Psychology 2006, 73:90-99.
6. Filip M., Wydra K., Inan S.Y., Dziedzicka-Wasylewska M., Przegalinski E. Opioid and monoamine systems mediate the discriminative stimulus of tramadol in rats. European Journal of Pharmacology 2004, 498:143-151.
7. Hickman M., Madden P., Henry J., Baker A., Wallace C., Wakefield J., Stimson G., Elliott P. Trends in drug overdose deaths in England and Wales 1993-98: methadone does not kill more people than heroin. Addiction 2003, 98:419-425.
8. Knisely J.S., Campbell E.D., Dawson K.S., Schnoll S.H. Tramadol post-marketing surveillance in health care professionals. Drug and Alcohol Dependence 2002, 68:15-22.
9. Lehmann K.A. Tramadol for the management of acute pain. Drugs 1994, 47(Suppl. 1):19-32.
10. Li C., Chen H.F. 1158 cases report of heroin dependence. Medical Journal of Chinese People's Health 2011, 23:595-596.
11. Li Y.Q., Li F.Q., Wang X.Y., Wu P., Zhao M., Xu C.M., Shaham Y., Lu L. Central amygdala extracellular signal-regulated kinase signaling pathway is critical to incubation of opiate craving. Journal of Neuroscience 2008, 28:13248-13257.
12. Liang J.H., Wang K., Sun H.L., Han R. Potentiating effect of tramadol on methamphetamine-induced behavioral sensitization in mice. Psychopharmacology 2006, 185:1-10.
13. Liu C.J., Qi L., Yang J. Survey of tramadol addiction in drug treatment agencies in Ningxia province. Journal of Ningxia Medical University 2011, 33:67-69.
14. Liu Z.M., Zhou W.H., Lian Z., Mu Y., Cao J.Q., Cai Z.J., Yang Z., Song S.L., Gong W.L., Wang X.P., Teng Y.Q., Cai D.Y., Zhu G.R. Epidemiological survey on poly-drug abuse among addicts. Chinese Journal of Clinical Pharmacology 2000, 16:272-276.
15. Liu Z.M., Zhou W.H., Lian Z., Mu Y., Ren Z.H., Cao J.Q., Cai Z.J. Drug dependence and abuse potential of tramadol. Acta Pharmacologica Sinica 1999, 20:52-54.
16. Marquez P., Baliram R., Kieffer B.L., Lutfy K. The mu opioid receptor is involved in buprenorphine-induced locomotor stimulation and conditioned place preference. Neuropharmacology 2007, 52:1336-1341.
17. Matthes H.W., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dolle P., Tzavara E., Hanoune J., Roques B.P., Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 1996, 383:819-823.
18. Nakamura A., Narita M., Miyoshi K., Shindo K., Okutsu D., Suzuki M., Higashiyama K., Suzuki T. Changes in the rewarding effects induced by tramadol and its active metabolite M1 after sciatic nerve injury in mice. Psychopharmacology 2008, 200:307-316.
19. O'Connor E.C., Mead A.N. Tramadol acts as a weak reinforcer in the rat self-administration model, consistent with its low abuse liability in humans. Pharmacology Biochemistry and Behavior 2010, 96:279-286.
20. Raffa R.B., Friderichs E., Reimann W., Shank R.P., Codd E.E., Vaught J.L. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. Journal of Pharmacology and Experimental Therapeutics 1992, 260:275-285.
21. Ren Y.H., Zheng J.W. Influence of tramadol on morphine discriminative behavior in rats. Acta Pharmacologica Sinica 2000, 21:924-926.
22. Scott L.J., Perry C.M. Tramadol: a review of its use in perioperative pain. Drugs 2000, 60:139-176.
23. Sprague J.E., Leifheit M., Selken J., Milks M.M., Kinder D.H., Nichols D.E. In vivo microdialysis and conditioned place preference studies in rats are consistent with abuse potential of tramadol. Synapse 2002, 43:118-121.
24. Thorn D.A., Winter J.C., Li J.X. Agmatine attenuates methamphetamine-induced conditioned place preference in rats. European Journal of Pharmacology 2012, 680:69-72.
25. Tzschentke T.M. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addiction Biology 2007, 12:227-462.
26. Tzschentke T.M., Bruckmann W., Friderichs E. Lack of sensitization during place conditioning in rats is consistent with the low abuse potential of tramadol. Neuroscience Letters 2002, 329:25-28.
27. Yanagita T. Drug dependence potential of 1-(m-methoxyphenyl)-2-dimethylaminomethyl)-cyclohexan-1-ol hydrochloride (tramadol) tested in monkeys. Arzneimittel-Forschung 1978, 28:158-163.